U: 18% | Unity Software shares are trading higher after the company issued preliminary Q1 2026 revenue guidance that exceeded its earlier outlook

 

AZN: 3% | AstraZeneca shares are trading higher after the company announced results from its Phase III OBERON and TITANIA trials in patients with chronic obstructive pulmonary disease, which showed that tozorakimab reduced the annualized rate of moderate-to-severe COPD exacerbations compared with placebo.

 

ONCO: 87% | Onconetix, Inc. did a 1-for-5 reverse splits. Onconetix, Inc. General Corporate Statement (Form8)